Novo Nordisk A/S vs Vipshop Holdings Ltd - ADR — how do they compare? Novo Nordisk A/S trades at $49.35 (market cap $220.53B), while Vipshop Holdings Ltd - ADR trades at $14.63 (market cap $7.01B). The key difference: Novo Nordisk A/S is far larger — about 31.5× Vipshop Holdings Ltd - ADR's market cap, and Vipshop Holdings Ltd - ADR pays the higher dividend (4.25%). Which is the better fit depends on your goals.
| NVO | VIPS | |
|---|---|---|
Market Cap | $220.53B | $7.01B |
Sector | Health | Consumer Cyclical |
52-Week High | $71.70 | $20.68 |
52-Week Low | $35.29 | $12.92 |
Enterprise Value | $239.49B | $3.60B |
Dividend Yield | 3.63% | 4.25% |
Trailing returns across standard periods
Latest headlines on both assets
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →